Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

GenSight investment profits from gene therapy buzz

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

AstraZeneca Binds to biologics for new strategy Horizon

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Santhera seeks US partner for DMD program

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , | Leave a comment

David Motts’ NEA weighs in on rare diseases

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Shire starts year with flurry of deals

Authored by James Sheppard

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , | Leave a comment

It’s as simple as ADC for Mersana Therapeutics

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap